Drawing for TISSUECYTOMETRY BY TISSUEGNOSTICS

USPTO serial 79356287

TISSUECYTOMETRY BY TISSUEGNOSTICS

Reviewed by CopyMark Law Group

Reg. 7601821Status 700Registered
Filing date
Status date
Registration date
Dec 17, 2024
Examiner
BLAZICH, JOAN MICHELE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TISSUECYTOMETRY BY TISSUEGNOSTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical products, namely, chemicals for industrial and scientific use; biological preparations for industrial and scientific use; diagnostic reagents for scientific use; diagnostics, namely, diagnostics staining kits comprised of diagnostic reagents for scientific use, and scanning computer hardware and downloadable analysis software for tissue cytometry, for scientific use; chemical diagnostic reagents for scientific use; indicators, namely, chemicals for scientific use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; in vitro diagnostic preparations, namely, antibody staining kits for scientific use comprised of diagnostic reagents and chemicals for scientific use; diagnostic reagents sold as a kit, the kit containing monoclonal antibodies and buffer solutions, other than for medical use; staining chemicals being fluorescence labelled monoclonal antibodies for scientific use; histological staining kits comprised of fluorescence labelled monoclonal antibodies and buffer solutions for scientific use; staining kits comprised of a combination of monoclonal antibodies relevant for specific diagnostic purposes, namely, for staining tissue sections for scientific use.ACTIVE
005Medical and veterinary diagnostic preparations for analysis of tissue sections, not limited to but including cancer tissue; diagnostic reagents for medical use; diagnostic agents being fluorescence-labelled antibody staining kits comprised of diagnostic reagents and chemicals for medical use; diagnostic reagents for in vitro use in the field of medicine; in vitro diagnostic preparations in the nature of antibody staining kits comprised of diagnostic reagents for diagnostics, for medical use; staining preparations in the nature of fluorescence-labelled staining kits comprised of diagnostic reagents and chemicals for medical use; staining kits comprised of monoclonal antibodies and buffer solutions for medical use; quantitative staining kits comprised of specific monoclonal antibodies labelled with specific sets of fluorochromes for medical use.ACTIVE
009Scientific, research, audiovisual, optical, weighing, measuring, signaling, detection, testing and inspecting apparatus and instruments, namely, microscope based digital slide scanners and tissue image cytometers; recorded and downloadable media, namely, microscopic images of tissue sections and cultures cells and organoids; downloadable and recorded computer software for management and analysis of microscopic images as well as image analysis and data visualization; computers and computer peripherals; downloadable and recorded software for evaluating medical samples for extracting information on tissue structures and cell populations relevant for understanding diseases and performing a diagnosis; downloadable and recorded software for evaluating scientific samples for visualization of cellular in-situ data; downloadable and recorded analysis software for analyzing tissue samples for the detection of specific disease status, not limited to but including cancer; downloadable and recorded analysis software for analyzing tissue samples stained with color reagents for immunohistochemistry and immunofluorescence; diagnostic apparatus for scientific use, namely, tissue image cytometers for analysis and diagnosis of human or veterinary tissue samples.ACTIVE
010Medical, surgical, therapeutic, dental and veterinary instruments and apparatus, namely, digital slide scanners; diagnostic apparatus and diagnostic measuring apparatus for medical use, namely, tissue image cytometers; analytical apparatus for histological use in the field of medicine, namely, tissue sample analyzers; analytical apparatus for medical purposes, namely, artificial intelligence-based decision support systems comprised of tissue image cytometers and sample analyzers for medical purposes, and downloadable computer software for analyzing tissue samples for detection of disease for histopathology.ACTIVE
042Scientific and technological services and research and design relating thereto, namely, scientific research and development services; industrial analysis and research services in the field of tissue research and histopathology; design and development of computer hardware and software; biological, clinical in the field of histology and medical research and analysis; histological medical research services; histological image analysis and tissue image cytometry development services; histological medical laboratory services; histological analysis, namely, cytometric analysis of tissue samples; consultancy services in the field of histology for scientific research and diagnostics; research and development of new products in the field of histology; research and development of microscopy-based diagnostic methods based on the analysis of tissue and cell cultures; analysis of human tissues for medical research; development of computer hardware and analytic software in the field of histology for scientific research and medical and clinical diagnostics.ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB
May 19, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB
May 19, 2025FIMPFINAL DISPOSITION PROCESSED
Mar 17, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 3, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Dec 17, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 15, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 9, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 3, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
May 21, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 1, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 1, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 8, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Mar 8, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 8, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 15, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 15, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 15, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2023RFNTREFUSAL PROCESSED BY IB
Aug 18, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 18, 2023RFRRREFUSAL PROCESSED BY MPU
Jul 22, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 21, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2023DOCKASSIGNED TO EXAMINER
Dec 6, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Dec 2, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance